MR-proADM as a Early Biomarker for DGF and AR in Kidney and Liver Transplantation
MR-proADM as a Early Biomarker for DGF and AR in Kidney and Liver Transplantation
Recruiting · NCT06130046 · Registry updated 2025-08-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| MR-proADM as a Early Biomarker for DGF and AR in Kidney and Liver Transplantation | Kidney Transplant; Complications; Liver Transplant; Complications | Recruiting | Not stated | 2025-08-01 | NCT06130046 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Rome Tor Vergata | 37 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Rome Tor Vergata | Rome | Italy | 2 |